LON:CREO

Creo Medical Group (CREO) Share Price, News & Analysis

Creo Medical Group logo
GBX 10.18 +0.06 (+0.54%)
As of 04:03 AM Eastern

About Creo Medical Group Stock (LON:CREO)

Advanced

Key Stats

Today's Range
10.08
▼
10.25
50-Day Range
9.67
▼
12.75
52-Week Range
9.50
▼
18.50
Volume
22,560 shs
Average Volume
747,953 shs
Market Capitalization
£45.72 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
GBX 40
Consensus Rating
N/A

Company Overview

Creo Medical is a medical device company focused on the development and commercialisation of minimally invasive electrosurgical devices, bringing advanced energy to endoscopy. The Company's vision is to improve patient outcomes through the development and commercialisation of a suite of electrosurgical medical devices, each enabled by CROMA, powered by Kamaptive. The Group has developed the CROMA powered by Kamaptive full-spectrum adaptive technology to optimise surgical capability and patient outcomes. Kamaptive is a seamless, intuitive integration of multi-modal energy sources, optimised to dynamically adapt to patient tissue during procedures such as resection, dissection, coagulation and ablation of tissue. Kamaptive technology provides clinicians with increased flexibility, precision and controlled surgical solutions. CROMA currently delivers bipolar radiofrequency ("RF") energy for precise localised cutting and focused high frequency microwave ("MW") energy for controlled coagulation and ablation via a single accessory port. This technology, combined with the Group's range of patented electrosurgical devices, is designed to provide clinicians with flexible, accurate and controlled clinical solutions. The Directors believe the Company's technology can impact the landscape of surgery and endoscopy by providing a safer, less-invasive and more cost-efficient option for procedures. For more information, please refer to the website www.creomedical.com

Receive CREO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Creo Medical Group and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

CREO Stock News Headlines

Creo Medical Group (LON:CREO) Stock Falls 1.2% - Should You Sell?
Pentagon magnet restrictions take effect January 1, 2027
A NASDAQ-listed company has signed a term sheet outlining a potential 75-year agreement with the U.S. Army. It would build and operate a rare earth processing facility on an active military base, with the Army receiving first right to production. The timing matters. New Pentagon restrictions on certain Chinese-origin rare earth magnets take effect January 1, 2027, while China controls more than 90% of global rare earth processing. The company's mine-to-magnet platform spans feedstock agreements, processing facilities, metallization technology, and downstream manufacturing, with initial commercial output targeted for 2027.tc pixel
See More Headlines

CREO Stock Analysis - Frequently Asked Questions

Creo Medical Group's stock was trading at GBX 10 on January 1st, 2026. Since then, CREO stock has increased by 0.7% and is now trading at GBX 10.08.

Creo Medical Group PLC (LON:CREO) announced its quarterly earnings data on Wednesday, September, 30th. The company reported GBX (2) EPS for the quarter. Creo Medical Group had a negative net margin of 268.57% and a negative trailing twelve-month return on equity of 38.29%.

Shares of CREO stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

Based on aggregate information from My MarketBeat watchlists, some other companies that Creo Medical Group investors own include Aviva (AV), ITM Power (ITM), Legal & General Group (LGEN), Lloyds Banking Group (LLOY), M&G (MNG), Avacta Group (AVCT) and Barclays (BARC).

Company Calendar

Last Earnings
9/30/2026
Today
11/18/2026

Industry, Sector and Symbol

Stock Exchange
LON
Industry
Healthcare Equipment & Supplies
Sub-Industry
N/A
Current Symbol
LON:CREO
CIK
N/A
Fax
N/A
Employees
279
Year Founded
N/A

Price Target and Rating

High Price Target
GBX 40
Low Price Target
GBX 40
Potential Upside/Downside
+290.2%
Consensus Rating
N/A
Rating Score (0-4)
0.00
Research Coverage
0 Analysts

Profitability

EPS (Trailing Twelve Months)
GBX (5)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-£25.04 million
Net Margins
-268.57%
Pretax Margin
N/A
Return on Equity
-38.29%
Return on Assets
-20.09%

Debt

Debt-to-Equity Ratio
8.09
Current Ratio
2.79
Quick Ratio
2.19

Sales & Book Value

Annual Sales
£7 million
Price / Sales
6.58
Cash Flow
GBX 4.22 per share
Price / Cash Flow
2.43
Book Value
GBX 13.11 per share
Price / Book
0.78

Miscellaneous

Outstanding Shares
449,140,000
Free Float
N/A
Market Cap
£46.04 million
Optionable
Not Optionable
Beta
1.56
The 7 Hottest IPO Stories of 2026 Cover

MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.

Get This Free Report

This page (LON:CREO) was last updated on 11/18/2026 by MarketBeat.com Staff.
From Our Partners